标题
Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
作者
关键词
-
出版物
Biomedicines
Volume 8, Issue 9, Pages 332
出版商
MDPI AG
发表日期
2020-09-07
DOI
10.3390/biomedicines8090332
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Emerging Roles of Activity-Dependent Alternative Splicing in Homeostatic Plasticity
- (2020) Agnes Thalhammer et al. Frontiers in Cellular Neuroscience
- An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
- (2019) Basil T. Darras et al. CNS DRUGS
- Disruption of splicing-regulatory elements using CRISPR/Cas9 rescues spinal muscular atrophy in human iPSCs and mice
- (2019) Jin-Jing Li et al. National Science Review
- Strategies for the CRISPR-Based Therapeutics
- (2019) Bin Li et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
- (2018) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
- (2018) Agnes Thalhammer et al. Jove-Journal of Visualized Experiments
- The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature
- (2018) E. Indelicato et al. EUROPEAN JOURNAL OF NEUROLOGY
- Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
- (2018) Juanjuan Yuan et al. MOLECULAR CELL
- RNA Splicing and Disease: Animal Models to Therapies
- (2018) Matías Montes et al. TRENDS IN GENETICS
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy
- (2017) Constantin d’Ydewalle et al. NEURON
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
- (2017) S. Ryder et al. Orphanet Journal of Rare Diseases
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Alternative Splicing of P/Q-Type Ca 2+ Channels Shapes Presynaptic Plasticity
- (2017) Agnes Thalhammer et al. Cell Reports
- Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
- (2017) Karima Relizani et al. Molecular Therapy-Nucleic Acids
- Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia
- (2017) Cèlia Sintas et al. Scientific Reports
- Genetic Variants Associated with Episodic Ataxia in Korea
- (2017) Kwang-Dong Choi et al. Scientific Reports
- Eye movement disorders are an early manifestation ofCACNA1Amutations in children
- (2016) Esther M Tantsis et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- mRNAtrans -splicing in gene therapy for genetic diseases
- (2016) Adeline Berger et al. Wiley Interdisciplinary Reviews-RNA
- Next-generation sequencing identifies novelCACNA1Agene mutations in episodic ataxia type 2
- (2016) Neven Maksemous et al. Molecular Genetics & Genomic Medicine
- Exon skipping therapy for Duchenne muscular dystrophy
- (2015) Ryszard Kole et al. ADVANCED DRUG DELIVERY REVIEWS
- CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms
- (2015) Lena Damaj et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature
- (2014) Wolfgang Nachbauer et al. JOURNAL OF NEUROLOGY
- A day in the life of the spliceosome
- (2014) A. Gregory Matera et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Genetics of Spinal Muscular Atrophy: Progress and Challenges
- (2014) Michelle A. Farrar et al. Neurotherapeutics
- Alternative-splicing-mediated gene expression
- (2014) Qianliang Wang et al. PHYSICAL REVIEW E
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders
- (2014) S. E. Soden et al. Science Translational Medicine
- Regulation of alternative splicing of tau exon 10
- (2014) Wei Qian et al. Neuroscience Bulletin
- Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing
- (2013) María Elena Avale et al. HUMAN MOLECULAR GENETICS
- Postnatal Loss of P/Q-Type Channels Confined to Rhombic-Lip-Derived Neurons Alters Synaptic Transmission at the Parallel Fiber to Purkinje Cell Synapse and Replicates Genomic Cacna1a Mutation Phenotype of Ataxia and Seizures in Mice
- (2013) T. Maejima et al. JOURNAL OF NEUROSCIENCE
- Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene
- (2013) Peng Wen Pao et al. MOLECULAR THERAPY
- Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood
- (2013) Chihiro Ohba et al. NEUROGENETICS
- Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
- (2013) Sarah L. DeVos et al. Neurotherapeutics
- Inhibition of RNA Helicase Brr2 by the C-Terminal Tail of the Spliceosomal Protein Prp8
- (2013) S. Mozaffari-Jovin et al. SCIENCE
- Control of neuronal voltage-gated calcium ion channels from RNA to protein
- (2013) Diane Lipscombe et al. TRENDS IN NEUROSCIENCES
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO)
- (2012) Simona Cavalieri et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste
- (2012) Verena Wally et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- Exon and intron definition in pre-mRNA splicing
- (2012) Laura De Conti et al. Wiley Interdisciplinary Reviews-RNA
- Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum
- (2011) Liutao Du et al. HUMAN MOLECULAR GENETICS
- Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia
- (2011) Kotoka Nakamura et al. HUMAN MUTATION
- Delayed Postnatal Loss of P/Q-Type Calcium Channels Recapitulates the Absence Epilepsy, Dyskinesia, and Ataxia Phenotypes of Genomic Cacna1A Mutations
- (2011) M. D. Mark et al. JOURNAL OF NEUROSCIENCE
- New mutation of CACNA1A gene in episodic ataxia type 2
- (2011) Koki Nikaido et al. PEDIATRICS INTERNATIONAL
- Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
- (2011) F. G. Osorio et al. Science Translational Medicine
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- Combination of SMN Trans-Splicing and a Neurotrophic Factor Increases the Life Span and Body Mass in a Severe Model of Spinal Muscular Atrophy
- (2010) Monir Shababi et al. HUMAN GENE THERAPY
- Congenital Ataxia, Mental Retardation, and Dyskinesia Associated With a Novel CACNA1A Mutation
- (2010) Lubov Blumkin et al. JOURNAL OF CHILD NEUROLOGY
- Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
- (2010) T. H. Coady et al. JOURNAL OF NEUROSCIENCE
- Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy
- (2010) Sanjeev Rajakulendran et al. JOURNAL OF PHYSIOLOGY-LONDON
- Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2
- (2010) Elide Mantuano et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q
- (2010) Nico Melzer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing
- (2010) Arturo Andrade et al. NATURE NEUROSCIENCE
- Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients
- (2010) A.T.J.M. Helderman-van den Enden et al. NEUROMUSCULAR DISORDERS
- CaV2.1 channelopathies
- (2010) Daniela Pietrobon PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- The Spliceosome: Design Principles of a Dynamic RNP Machine
- (2009) Markus C. Wahl et al. CELL
- Ribonuclease H: the enzymes in eukaryotes
- (2009) Susana M. Cerritelli et al. FEBS Journal
- Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
- (2009) T. Rodriguez-Martin et al. HUMAN MOLECULAR GENETICS
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhood
- (2009) P Bertholon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene
- (2009) Ester Cuenca-León et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cystic fibrosis
- (2009) Brian P O'Sullivan et al. LANCET
- Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Alternative splicing and disease
- (2008) Jamal Tazi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia and interictal chronic diarrhea due to a novel CACNA1A mutation
- (2008) D.I. Zafeiriou et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family
- (2008) A. Roubertie et al. JOURNAL OF NEUROLOGY
- Spinal muscular atrophy
- (2008) Mitchell R Lunn et al. LANCET
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2
- (2008) Tracey D. Graves et al. NEUROBIOLOGY OF DISEASE
- Stepwise Developmental Regression Associated With Novel CACNA1A Mutation
- (2008) Andrea A. Guerin et al. PEDIATRIC NEUROLOGY
- Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
- (2008) Tristan H. Coady et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now